Disease awareness talk: Ankylosing Spondylitis

Speciality: Rheumatology


Speaker:

Dr. Shriram Garg | Dermatologist

Description:

A warm welcome to all the medical professionals in this interesting session on Disease awareness talk: Ankylosing Spondylitis.
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints, leading to pain, stiffness, and eventual fusion of the vertebrae in severe cases. Early symptoms often include persistent lower back pain and stiffness, especially in the morning or after periods of inactivity. AS can also affect other areas of the body, such as the hips, shoulders, and even organs like the eyes (causing uveitis). Early detection is crucial in slowing the progression of the disease and preventing long-term disability.
During a disease awareness talk, it’s important to emphasize that AS typically begins in young adulthood and often goes undiagnosed for years due to its gradual onset. Effective management includes a combination of medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), biologics like TNF inhibitors, and physical therapy to maintain flexibility and mobility. Raising awareness about AS can help individuals recognize early symptoms, seek timely medical intervention, and improve their quality of life through appropriate treatment and lifestyle modifications.
Therefore, get an overall knowledge of Disease awareness talk: Ankylosing Spondylitis. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

2.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

3.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

4.

Report suggests a big improvement in lung cancer survival

5.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot